Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Get guidance on choosing ETFs over mutual funds for Sp 500 retirement investing. We cover cost, liquidity, and tax considerations to help decide.
25,646 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Biote's Q1 2026 earnings call reveals critical insights into revenue growth, margins, and a promising pipeline. This ...
As markets wobble in 2026, investors are turning to a core portfolio cornerstone built on durable, recurring revenue....
As investors eye small-cap medical devices, Inogen's INGN 2026 earnings story matters. This analysis breaks down Q1 r...
As macro realities fracture tech valuations, investors pivot toward durable cash flow. Meta Platforms stands out as a...
Opendoor's Q1 2026 earnings shed light on how the iBuying pioneer is balancing growth with cash discipline. This anal...
When a mining stock pops today, investors sit up. Discover the drivers behind SSR Mining's rally, what it means for r...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
Investors are weighing the latest earnings from First Majestic Silver. This article breaks down what the numbers mean...
Strategy's latest plan more has traders watching Bitcoin's moves closely. This article breaks down what the plan mean...
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
A high profile roast goes viral and reveals more than punchlines. This article uses the michael mocks white writers m...